(Q38850429)

7 September 2017

title

An important role of the hepcidin-ferroportin signaling in affecting tumor growth and metastasis (English)

1 reference

7 September 2017

Wenli Guo

1

1 reference

7 September 2017

Shuping Zhang

2

1 reference

7 September 2017

Yue Chen

3

1 reference

7 September 2017

Daoqiang Zhang

4

1 reference

7 September 2017

Lin Yuan

5

1 reference

7 September 2017

Haibo Cong

6

1 reference

7 September 2017

Sijin Liu

7

1 reference

7 September 2017

publication date

22 July 2015

1 reference

Acta Biochimica et Biophysica Sinica

7 September 2017

published in

1 reference

7 September 2017

volume

47

1 reference

7 September 2017

issue

9

1 reference

7 September 2017

page(s)

703-715

1 reference

Systemic iron homeostasis

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMV063

Hepcidin and iron regulation, 10 years later

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMV063

Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMV063

Disordered hepcidin-ferroportin signaling promotes breast cancer growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMV063

Ferroportin and Iron Regulation in Breast Cancer Progression and Prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMV063

Anemia and iron biomarkers in patients with early breast cancer. Diagnostic value of hepcidin and soluble transferrin receptor quantification

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMV063

Immunoassay for human serum hepcidin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMV063

In anemia of multiple myeloma, hepcidin is induced by increased bone morphogenetic protein 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMV063

Hepcidin, anaemia, and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMV063

Regulation of cellular iron metabolism and its implications in lung cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMV063

Heparin as an inhibitor of cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMV063

The molecular basis of ferroportin-linked hemochromatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMV063

NANOG-dependent function of TET1 and TET2 in establishment of pluripotency

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMV063

Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMV063

IRP2 regulates breast tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMV063

Deregulation of proteins involved in iron metabolism in hepcidin-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMV063

Minihepcidins prevent iron overload in a hepcidin-deficient mouse model of severe hemochromatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMV063

Disordered signaling governing ferroportin transcription favors breast cancer growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMV063

ROCK has a crucial role in regulating prostate tumor growth through interaction with c-Myc

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMV063

AG490: an inhibitor of hepcidin expression in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMV063

Nutritional iron supplementation studies based on enriched (57) Fe, added to milk in rats, and isotope pattern deconvolution-ICP-MS analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMV063

Nanosilver incurs an adaptive shunt of energy metabolism mode to glycolysis in tumor and nontumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMV063

Targeted disruption of the hepcidin 1 gene results in severe hemochromatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMV063

A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMV063

Functional differences between hepcidin 1 and 2 in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMV063

Iron and cancer: more ore to be mined

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMV063

A novel mammalian iron-regulated protein involved in intracellular iron metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMV063

Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMV063

Regulation of iron metabolism by hepcidin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMV063

Polychlorinated biphenyls (PCBs) enhance metastatic properties of breast cancer cells by activating Rho-associated kinase (ROCK)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMV063

Bromodeoxyuridine: a diagnostic tool in biology and medicine, Part III. Proliferation in normal, injured and diseased tissue, growth factors, differentiation, DNA replication sites and in situ hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMV063

Graphene oxide induces toll-like receptor 4 (TLR4)-dependent necrosis in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMV063

Central role of Snail1 in the regulation of EMT and resistance in cancer: a target for therapeutic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMV063

The roles of HLH transcription factors in epithelial mesenchymal transition and multiple molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMV063

Evolutionary functional analysis and molecular regulation of the ZEB transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMV063

Catabolic metabolism during cancer EMT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMV063

The nutritional phenome of EMT-induced cancer stem-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMV063

Role of pyruvate kinase M2 in transcriptional regulation leading to epithelial-mesenchymal transition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMV063

21 January 2018

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMV063

Breast cancer statistics, 2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMV063

Metastasis: from dissemination to organ-specific colonization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMV063

Tumor metastasis: molecular insights and evolving paradigms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMV063

Iron homeostasis and tumorigenesis: molecular mechanisms and therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMV063

Cellular iron metabolism in prognosis and therapy of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMV063

RETRACTED: Ferroportin in the progression and prognosis of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMV063

An iron regulatory gene signature predicts outcome in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMV063

Key signalling nodes in mammary gland development and cancer. The Snail1-Twist1 conspiracy in malignant breast cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMV063

Vimentin in cancer and its potential as a molecular target for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMV063

The epithelial-mesenchymal transition (EMT) phenomenon

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMV063

The ins and outs of the epithelial to mesenchymal transition in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMV063

Regulatory networks defining EMT during cancer initiation and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMV063

Novel clinical therapeutics targeting the epithelial to mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMV063

Clinical significance of epithelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMV063

Altered energy metabolism in cancer: a unique opportunity for therapeutic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMV063

Tumor bioenergetics: an emerging avenue for cancer metabolism targeted therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMV063

21 January 2018

Identifiers

DOI

10.1093/ABBS/GMV063

1 reference

7 September 2017

1 reference